Rocket Pharmaceuticals Inc.: Clinical Trials

5 trials sponsored by Rocket Pharmaceuticals Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting, 1 suspended. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Active not recruiting 1, Completed 1, Recruiting 1, Suspended 1, Unknown 1
Phase 11Completed 1

Follow Rocket Pharmaceuticals Inc.: new trials by email

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase Deficiency
RP-L301 - Pyruvate Kinase Deficiency
Phase 2SuspendedRocket Pharmaceuticals Inc.102026-04-012026-04-16
A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
RP-A501 - Danon Disease
Phase 2RecruitingRocket Pharmaceuticals Inc.182023-09-052026-10-06
Gene Therapy for Fanconi Anemia, Complementation Group A
RP-L102 - Fanconi Anemia Complementation Group A
Phase 2Active not recruitingRocket Pharmaceuticals Inc.52020-07-152025-12-22
Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A
RP-L102 - Fanconi Anemia Complementation Group A
Phase 2UnknownRocket Pharmaceuticals Inc.72019-11-282024-05-22
A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I
RP-L201 - Leukocyte Adhesion Defect - Type I
Phase 1 / Phase 2CompletedRocket Pharmaceuticals Inc.92019-08-302023-11-15

Conditions studied

Anemia (2)  ·  Bone Marrow Failure Disorders (2)  ·  Fanconi Syndrome (2)  ·  Cardiomyopathies (1)  ·  Cardiomyopathy, Hypertrophic (1)  ·  Glycogen Storage Disease Type IIb (1)  ·  Hypertrophy, Left Ventricular (1)  ·  Leukocyte adhesion deficiency type 1 (1)  ·  Lysosomal Storage Diseases (1)  ·  Pyruvate Kinase Deficiency of Red Cells (1)

Interventions

Methods (1)  ·  Therapeutics (1)

Countries

United States (4)  ·  Spain (3)  ·  United Kingdom (3)  ·  Germany (1)  ·  Italy (1)

Top investigators

Ami Shah, MD (1)  ·  Barry Greenberg, MD (1)  ·  Claire Booth, MBBS, PhD, MSc (1)  ·  Donald B Kohn, MD (1)  ·  Joseph Rossano, MD (1)  ·  Julian Sevilla Navarro, MD, PhD (1)  ·  Margaret MacMillan, MD, MSc (1)  ·  Maria Chitty-Lopez, MD (1)  ·  Rajni Agarwal, MD (1)

Results publications

PMID 40305711

NIH funding

2018 (1)